Search research articles
Contact Us
Filters
Showing results (51-60 of 136) with videos related to
Page
of 14
Sort By:
Urology
|
February 1, 1996
Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen
F Labrie, B Candas, L Cusan, et al.
Endocrinology
|
May 1, 1979
Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female rats
L Cusan, C Auclair, A Belanger, et al.
The Journal of Urology
|
March 1, 1992
Serum prostate specific antigen as pre-screening test for prostate cancer
F Labrie, A Dupont, R Suburu, et al.
The American Journal of Medicine
|
May 1, 1992
Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
J L Gomez, A Dupont, L Cusan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1994
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
A Bélanger, B Candas, A Dupont, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 9, 2005
Major impact of hormonal therapy in localized prostate cancer--death can already be an exception
Fernand Labrie, Leonello Cusan, José Gomez, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 20, 2013
Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens
Fernand Labrie, Céline Martel, René Bérubé, et al.
Journal of Steroid Biochemistry
|
June 1, 1989
Influence of diet on plasma steroids and sex hormone-binding globulin levels in adult men
A Bélanger, A Locong, C Noel, et al.
Urology
|
March 30, 1999
Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy
T H van der Kwast, B Têtu, B Candas, et al.
Sexually Transmitted Diseases
|
May 23, 2000
Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Italian Herpes Forum
M Cusini, M Cusan, C Parolin, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 136) with videos related to
Sort By:
Page
of 14
Urology
|
February 1, 1996
Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen
F Labrie, B Candas, L Cusan, et al.
Endocrinology
|
May 1, 1979
Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female rats
L Cusan, C Auclair, A Belanger, et al.
The Journal of Urology
|
March 1, 1992
Serum prostate specific antigen as pre-screening test for prostate cancer
F Labrie, A Dupont, R Suburu, et al.
The American Journal of Medicine
|
May 1, 1992
Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
J L Gomez, A Dupont, L Cusan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1994
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
A Bélanger, B Candas, A Dupont, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 9, 2005
Major impact of hormonal therapy in localized prostate cancer--death can already be an exception
Fernand Labrie, Leonello Cusan, José Gomez, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 20, 2013
Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens
Fernand Labrie, Céline Martel, René Bérubé, et al.
Journal of Steroid Biochemistry
|
June 1, 1989
Influence of diet on plasma steroids and sex hormone-binding globulin levels in adult men
A Bélanger, A Locong, C Noel, et al.
Urology
|
March 30, 1999
Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy
T H van der Kwast, B Têtu, B Candas, et al.
Sexually Transmitted Diseases
|
May 23, 2000
Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Italian Herpes Forum
M Cusini, M Cusan, C Parolin, et al.
Page
of 14